Immature Platelets As a Predictor of Disease Severity and Mortality in Sepsis and Septic Shock: A Systematic Review

Abstract

Sepsis is associated with high morbidity and mortality, and short-term mortality remains above 30% despite relevant supportive and antibiotic treatments. The aim of this systematic review was to summarize and discuss the current evidence of the association of an increased number of circulating immature platelets with disease severity and mortality in patients with sepsis or septic shock. The review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement and was registered at the PROSPERO database (registration number: CRD42018104326). A systematic literature search was performed in PubMed, Web of Science, Scopus, and Embase on June 20, 2018, without time restrictions. The included studies were quality-assessed by the National Institutes of Health's Quality Assessment Tools. In total, 14 studies were included. The parameters used for the determination of platelet maturity were mean platelet volume, immature platelets fraction, reticulated platelet percentage, and absolute immature platelets count. Nine studies reported significantly increased immature platelet markers in nonsurvivors of septic shock compared with survivors, as well as in patients with severe sepsis or septic shock compared with patients without severe sepsis and septic shock. Six of these nine studies demonstrated that increased immature platelet markers were predictors of mortality and/or disease severity (area under the receiver operating curve: 0.599–0.886). This review suggests that an increased number of circulating immature platelets is associated with increased disease severity and mortality in patients with sepsis and septic shock. Larger studies are needed to confirm whether immature platelets should be routinely monitored to support the prediction of disease severity and mortality in septic patients.

Keywords

immature platelets - immature platelet fraction - mean platelet volume - mortality - biomarkers - septic shock - sepsis

Publication History

Publication Date:
13 December 2019 (online)

• References

• 1 Stevenson EK, Rubenstein AR, Radin GT, Wiener RS, Walkey AJ. Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis. Crit Care Med 2014; 42 (03) 625-631
• 2 Liu VX, Fielding-Singh V, Greene JD. et al. The timing of early antibiotics and hospital mortality in sepsis. Am J Respir Crit Care Med 2017; 196 (07) 856-863
• 3 Ferrer R, Martin-Loeches I, Phillips G. et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med 2014; 42 (08) 1749-1755
• 4 Kim HI, Park S. Sepsis: early recognition and optimized treatment. Tuberc Respir Dis (Seoul) 2019; 82 (01) 6-14
• 5 Dellinger RP, Carlet JM, Masur H. et al; Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32 (03) 858-873
• 6 Singer M, Deutschman CS, Seymour CW. et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 2016; 315 (08) 801-810
• 7 Kumar S, Tripathy S, Jyoti A, Singh SG. Recent advances in biosensors for diagnosis and detection of sepsis: a comprehensive review. Biosens Bioelectron 2019; 124-125: 205-215
• 8 Giannakopoulos K, Hoffmann U, Ansari U. et al. The use of biomarkers in sepsis: a systematic review. Curr Pharm Biotechnol 2017; 18 (06) 499-507
• 9 Li Z, Yang F, Dunn S, Gross AK, Smyth SS. Platelets as immune mediators: their role in host defense responses and sepsis. Thromb Res 2011; 127 (03) 184-188
• 10 Levi M, Sivapalaratnam S. Disseminated intravascular coagulation: an update on pathogenesis and diagnosis. Expert Rev Hematol 2018; 11 (08) 663-672
• 11 Thiery-Antier N, Binquet C, Vinault S, Meziani F, Boisramé-Helms J, Quenot JP. EPIdemiology of Septic Shock Group. Is thrombocytopenia an early prognostic marker in septic shock?. Crit Care Med 2016; 44 (04) 764-772
• 12 Greco E, Lupia E, Bosco O, Vizio B, Montrucchio G. Platelets and multi-organ failure in sepsis. Int J Mol Sci 2017; 18 (10) 2200
• 13 de Stoppelaar SF, van 't Veer C, van der Poll T. The role of platelets in sepsis. Thromb Haemost 2014; 112 (04) 666-677
• 14 Salvagno GL, Montagnana M, Degan M. et al. Evaluation of platelet turnover by flow cytometry. Platelets 2006; 17 (03) 170-177
• 15 Meintker L, Haimerl M, Ringwald J, Krause SW. Measurement of immature platelets with Abbott CD-Sapphire and Sysmex XE-5000 in haematology and oncology patients. Clin Chem Lab Med 2013; 51 (11) 2125-2131
• 16 Xu K, Chan NC, Hirsh J. et al. Quantifying immature platelets as markers of increased platelet production after coronary artery bypass grafting surgery. Eur J Haematol 2018; 101 (03) 362-367
• 17 Hong H, Xiao W, Maitta RW. Steady increment of immature platelet fraction is suppressed by irradiation in single-donor platelet components during storage. PLoS One 2014; 9 (01) e85465
• 18 Hoffmann JJ. Reticulated platelets: analytical aspects and clinical utility. Clin Chem Lab Med 2014; 52 (08) 1107-1117
• 19 Sachdev R, Tiwari AK, Goel S, Raina V, Sethi M. Establishing biological reference intervals for novel platelet parameters (immature platelet fraction, high immature platelet fraction, platelet distribution width, platelet large cell ratio, platelet-X, plateletcrit, and platelet distribution width) and their correlations among each other. Indian J Pathol Microbiol 2014; 57 (02) 231-235
• 20 Pons I, Monteagudo M, Lucchetti G. et al. Correlation between immature platelet fraction and reticulated platelets. Usefulness in the etiology diagnosis of thrombocytopenia. Eur J Haematol 2010; 85 (02) 158-163
• 21 de Wit N, Oosting J, Hoffmann J, Krockenberger M, van Dun L. Comparative evaluation of the Abbott CELL-DYN Sapphire reticulated platelets fraction and the Sysmex Xe-2100 IPF. Int J Lab Hematol 2009; 31 (Suppl. 01) 98
• 22 Choi SW, Kim BB, Choi DH. et al. Stroke or left atrial thrombus prediction using antithrombin III and mean platelet volume in patients with nonvalvular atrial fibrillation. Clin Cardiol 2017; 40 (11) 1013-1019
• 23 Kovács S, Csiki Z, Zsóri KS, Bereczky Z, Shemirani AH. Characteristics of platelet count and size and diagnostic accuracy of mean platelet volume in patients with venous thromboembolism. A systematic review and meta-analysis. Platelets 2019; 30 (02) 139-147
• 24 Balli M, Taşolar H, Çetin M. et al. Relationship of platelet indices with acute stent thrombosis in patients with acute coronary syndrome. Postepy Kardiol Interwencyjnej 2015; 11 (03) 224-229
• 25 Bath PM, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996; 7 (02) 157-161
• 26 Thompson CB, Jakubowski JA, Quinn PG, Deykin D, Valeri CR. Platelet size as a determinant of platelet function. J Lab Clin Med 1983; 101 (02) 205-213
• 27 Oh GH, Chung SP, Park YS. et al. Mean platelet volume to platelet count ratio as a promising predictor of early mortality in severe sepsis. Shock 2017; 47 (03) 323-330
• 28 Muronoi T, Koyama K, Nunomiya S. et al. Immature platelet fraction predicts coagulopathy-related platelet consumption and mortality in patients with sepsis. Thromb Res 2016; 144: 169-175
• 29 Liberati A, Altman DG, Tetzlaff J. et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009; 62 (10) e1-e34
• 30 National Institutes of Health. National Heart, Lung, and Blood Institute. Study Quality Assessment Tools. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools . Accessed November 8, 2018
• 31 Becchi C, Al Malyan M, Fabbri LP, Marsili M, Boddi V, Boncinelli S. Mean platelet volume trend in sepsis: is it a useful parameter?. Minerva Anestesiol 2006; 72 (09) 749-756
• 32 Acikgoz S, Akduman D, Eskici Z. et al. Thrombocyte and erythrocyte indices in sepsis and disseminated intravascular coagulation. J Med Biochem 2012; 31 (01) 60-64
• 33 Guclu E, Durmaz Y, Karabay O. Effect of severe sepsis on platelet count and their indices. Afr Health Sci 2013; 13 (02) 333-338
• 34 Sadaka F, Donnelly P, Griffin M, O'Brien J, Lakshmanan R. Mean platelet volume is not a useful predictor of mortality in septic shock. J Blood Disord Transfus 2014; 5 (02) 194
• 35 Gao Y, Li Y, Yu X. et al. The impact of various platelet indices as prognostic markers of septic shock. PLoS One 2014; 9 (08) e103761
• 36 Kim CH, Kim SJ, Lee MJ. et al. An increase in mean platelet volume from baseline is associated with mortality in patients with severe sepsis or septic shock. PLoS One 2015; 10 (03) e0119437
• 37 Orak M, Karakoç Y, Ustundag M, Yildirim Y, Celen MK, Güloglu C. An investigation of the effects of the mean platelet volume, platelet distribution width, platelet/lymphocyte ratio, and platelet counts on mortality in patents with sepsis who applied to the emergency department. Niger J Clin Pract 2018; 21 (05) 667-671
• 38 Montero-Chacón LB, Padilla-Cuadra JI, Chiou SH, Torrealba-Acosta G. High-density lipoprotein, mean platelet volume, and uric acid as biomarkers for outcomes in patients with sepsis: an observational study. J Intensive Care Med 2018; (e-pub ahead of print)
• 39 Enz Hubert RM, Rodrigues MV, Andreguetto BD. et al. Association of the immature platelet fraction with sepsis diagnosis and severity. Sci Rep 2015; 5: 8019
• 40 Park SH, Ha SO, Cho YU, Park CJ, Jang S, Hong SB. Immature platelet fraction in septic patients: clinical relevance of immature platelet fraction is limited to the sensitive and accurate discrimination of septic patients from non-septic patients, not to the discrimination of sepsis severity. Ann Lab Med 2016; 36 (01) 1-8
• 41 Koyama K, Katayama S, Muronoi T. et al. Time course of immature platelet count and its relation to thrombocytopenia and mortality in patients with sepsis. PLoS One 2018; 13 (01) e0192064
• 42 Liu QH, Song MY, Yang BX, Xia RX. Clinical significance of measuring reticulated platelets in infectious diseases. Medicine (Baltimore) 2017; 96 (52) e9424
• 43 Tajarernmuang P, Phrommintikul A, Limsukon A, Pothirat C, Chittawatanarat K. The role of mean platelet volume as a predictor of mortality in critically ill patients: a systematic review and meta-analysis. Crit Care Res Pract 2016; 2016 (16) 4370834
• 44 World Health Organization. Improving the Prevention, Diagnosis and Clinical Management of Sepsis. http://apps.who.int/gb/ebwha/pdf_files/WHA70/A70_13-en.pdf . Accessed April 13, 2018
• 45 GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 385 (9963): 117-171
• 46 Freund Y, Lemachatti N, Krastinova E. et al; French Society of Emergency Medicine Collaborators Group. Prognostic accuracy of sepsis-3 criteria for in-hospital mortality among patients with suspected infection presenting to the emergency department. JAMA 2017; 317 (03) 301-308